{"id":4160,"date":"2025-05-15T11:21:58","date_gmt":"2025-05-15T08:21:58","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4160"},"modified":"2025-05-15T11:21:59","modified_gmt":"2025-05-15T08:21:59","slug":"kucuk-cocuklari-etkileyen-rsvnin-saglikta-maliyeti-24-milyar-tlnin-uzerinde","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4160","title":{"rendered":"K\u00fc\u00e7\u00fck \u00c7ocuklar\u0131 Etkileyen RSV\u2019nin Sa\u011fl\u0131kta Maliyeti 24 Milyar TL\u2019nin \u00dczerinde"},"content":{"rendered":"\n

\u2018T\u00fcrkiye\u2019de Respiratuar Sinsityal Vir\u00fcs (RSV) Enfeksiyonu Ekonomik Y\u00fck \u00c7al\u0131\u015fmas\u0131\u2019 sonu\u00e7lar\u0131 a\u00e7\u0131kland\u0131. \u00dclkemizde bir ilk olma \u00f6zelli\u011fine sahip olan \u00e7al\u0131\u015fmaya g\u00f6re RSV\u2019nin \u00fclkemizdeki maliyeti 24 milyar TL\u2019yi a\u015f\u0131yor.<\/strong><\/p>\n\n\n\n

Bebeklerde ya\u015fam\u0131 tehdit eden \u015fiddetli solunum yolu enfeksiyonlar\u0131na yol a\u00e7an RSV\u2019yi konu alan bu ilk raporun sonu\u00e7lar\u0131n\u0131 Ba\u015fkent \u00dcniversitesi Sa\u011fl\u0131k Y\u00f6netimi B\u00f6l\u00fcm\u00fc \u00d6\u011fretim \u00dcyesi Prof. Dr. Simten Malhan bug\u00fcn bir bas\u0131n toplant\u0131s\u0131nda a\u00e7\u0131klad\u0131. Bas\u0131n toplant\u0131s\u0131na kat\u0131lan Hacettepe \u00dcniversitesi \u00c7ocuk Enfeksiyon B\u00f6l\u00fcm\u00fc \u00d6\u011fretim G\u00f6revlisi Prof Dr. Ate\u015f Kara da RSV hakk\u0131nda \u00f6nemli bilgiler payla\u015ft\u0131.<\/strong><\/strong><\/p>\n\n\n\n

T\u00fcrkiye i\u00e7in 0-5 ya\u015f aras\u0131 \u00e7ocuklarda \u00f6nemli bir hastal\u0131k y\u00fck\u00fc olu\u015fturan RSV enfeksiyonunun ekonomik y\u00fck\u00fc de olduk\u00e7a a\u011f\u0131r. Sa\u011fl\u0131k sistemlerini olumsuz y\u00f6nde etkileyen bu y\u00fck\u00fc ortaya koymak amac\u0131yla ger\u00e7ekle\u015ftirilen ve alan\u0131nda bir ilk olan \u2018T\u00fcrkiye\u2019de Respiratuar Sinsityal Vir\u00fcs Epidemiyolojisi, Tan\u0131 ve Tedavisi, Ekonomik Y\u00fck\u00fc\u2019<\/strong> raporu \u00e7arp\u0131c\u0131 sonu\u00e7lar\u0131 ortaya koydu. \u00c7al\u0131\u015fmay\u0131 ger\u00e7ekle\u015ftiren Ba\u015fkent \u00dcniversitesi Sa\u011fl\u0131k Y\u00f6netimi B\u00f6l\u00fcm\u00fc \u00d6\u011fretim \u00dcyesi \u0130yi Klinik Uygulamalar M\u00fckemmeliyet Merkezi Proje Direkt\u00f6r\u00fc Prof. Dr. Simten Malhan, <\/strong>toplant\u0131da RSV ve ekonomik y\u00fck\u00fc ile ilgili dikkat \u00e7ekici bilgiler payla\u015f\u0131rken Hacettepe \u00dcniversitesi \u00c7ocuk Enfeksiyon B\u00f6l\u00fcm\u00fc \u00d6\u011fretim G\u00f6revlisi Prof. Dr. Ate\u015f Kara <\/strong>da vir\u00fcs ile ilgili \u00f6nemli bilgiler payla\u015ft\u0131. <\/p>\n\n\n\n

Bebeklerin neredeyse tamam\u0131 ilk iki y\u0131l i\u00e7inde RSV\u2019ye yakalan\u0131yor<\/strong><\/p>\n\n\n\n

Rapordan \u00e7\u0131kan verilere g\u00f6re, s\u00fct \u00e7ocuklar\u0131n\u0131n yakla\u015f\u0131k y\u00fczde 50\u2019si ya\u015famlar\u0131n\u0131n ilk RSV sezonunda enfekte olurken, yakla\u015f\u0131k y\u00fczde 95\u2019i ya\u015famlar\u0131n\u0131n ilk iki y\u0131l\u0131 i\u00e7erisinde RSV ile enfekte oluyor. RSV\u2019ye kar\u015f\u0131 geli\u015fen ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n kal\u0131c\u0131 olmamas\u0131 nedeniyle enfeksiyon tekrarlayabiliyor; ast\u0131m ataklar\u0131n\u0131n \u015fiddetlenmesi ve KOAH gibi uzun vadeli solunum sorunlar\u0131na yol a\u00e7abiliyor. T\u00dc\u0130K do\u011fum istatistikleri, Uzman Paneli g\u00f6r\u00fc\u015fleri ve bilimsel kaynaklar \u0131\u015f\u0131\u011f\u0131nda yap\u0131lan \u00e7al\u0131\u015fmada, 2019-2023 y\u0131llar\u0131 aras\u0131nda do\u011fan toplam 0-5 ya\u015f aras\u0131 5 milyonu a\u015fk\u0131n \u00e7ocuktan 894 binden fazlas\u0131n\u0131n RSV\u2019ye yakaland\u0131\u011f\u0131 tahmin ediliyor. \u00c7al\u0131\u015fmaya g\u00f6re RSV\u2019ye yakalanan \u00e7ocuklar\u0131n 791 bin kadar\u0131 ayakta tedavi g\u00f6r\u00fcrken, 102 bin kadar\u0131 hastanede yatarak; 12 bine yak\u0131n\u0131 da yo\u011fun bak\u0131mda tedavi g\u00f6r\u00fcyor. 952 bebe\u011fin ise bu vir\u00fcsle ba\u011flant\u0131l\u0131 olarak hayat\u0131n\u0131 kaybetti\u011fi tahmin ediliyor.  <\/p>\n\n\n\n

RSV, Sa\u011fl\u0131k Hizmetlerinde B\u00fcy\u00fck Bir Ekonomik Y\u00fck! <\/strong><\/p>\n\n\n\n

Raporda, Hastal\u0131k Maliyeti Metodolojisi (COI) kapsam\u0131nda RSV\u2019nin \u00f6nemli hastal\u0131k ve manevi y\u00fck olmas\u0131n\u0131n yan\u0131 s\u0131ra ekonomik olarak da ciddi bir y\u00fck olu\u015fturdu\u011funa dikkat \u00e7ekiliyor. \u00c7al\u0131\u015fma kapsam\u0131nda yap\u0131lan analizlere g\u00f6re; 0\u20135 ya\u015f grubundaki 894.426<\/strong> hastan\u0131n toplam ekonomik y\u00fck\u00fc 24,2 milyar TL<\/strong> olarak hesaplan\u0131yor. Bu toplam y\u00fck, 2023 toplam sa\u011fl\u0131k harcamas\u0131n\u0131n y\u00fczde <\/strong>1,95\u2019ini<\/strong> ve 2023 SGK sa\u011fl\u0131k harcamas\u0131n\u0131n y\u00fczde <\/strong>4,62\u2019sini<\/strong> olu\u015fturuyor. <\/p>\n\n\n\n

\u201cRapor RSV y\u00fck\u00fcn\u00fc bilimsel ve rakamsal olarak g\u00f6zler \u00f6n\u00fcne serdi\u201d<\/strong><\/p>\n\n\n\n

Ba\u015fkent \u00dcniversitesi Sa\u011fl\u0131k Y\u00f6netimi B\u00f6l\u00fcm\u00fc \u00d6\u011fretim \u00dcyesi \u0130yi Klinik Uygulamalar M\u00fckemmeliyet Merkezi Proje Direkt\u00f6r\u00fc Prof. Dr. Simten Malhan, <\/strong>RSV\u2019nin \u00f6zellikle bebekler, ya\u015fl\u0131lar ve ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 zay\u0131f bireylerde ciddi solunum yolu enfeksiyonlar\u0131na yol a\u00e7t\u0131\u011f\u0131n\u0131 belirterek, \u201cRSV, \u00e7ocukluk \u00e7a\u011f\u0131 alt solunum yolu enfeksiyonlar\u0131n\u0131n ve hastane yat\u0131\u015flar\u0131n\u0131n en yayg\u0131n nedeni. Acil servis yo\u011funlu\u011fu, hastane yat\u0131\u015flar\u0131, sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 \u00fczerindeki bask\u0131 ve ailelerin ya\u015fad\u0131\u011f\u0131 maddi-manevi zorluklar, vir\u00fcs\u00fcn sa\u011fl\u0131k sistemleri ve toplum \u00fczerinde olu\u015fturdu\u011fu y\u00fcklerin ba\u015f\u0131nda geliyor.<\/p>\n\n\n\n

Alan\u0131nda \u00f6nde gelen uzmanlar\u0131n katk\u0131lar\u0131yla haz\u0131rlanan ve T\u00fcrkiye\u2019de ilk olan \u2018T\u00fcrkiye\u2019de Respiratuar Sinsityal Vir\u00fcs Epidemiyolojisi, Tan\u0131 ve Tedavisi, Ekonomik Y\u00fck\u00fc\u2019 raporunun bu y\u00fck\u00fc bilimsel ve rakamsal olarak g\u00f6zler \u00f6n\u00fcne sergiledi\u011fini vurgulayan Prof. Dr. Malhan, RSV\u2019nin d\u00fcnya genelinde benzer s\u0131kl\u0131kta g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc, \u00f6zellikle d\u00fc\u015f\u00fck ve orta gelirli \u00fclkelerde bu y\u00fck\u00fcn daha da a\u011f\u0131r oldu\u011funu ifade etti.<\/p>\n\n\n\n

Toplant\u0131da RSV\u2019ye ili\u015fkin bilgiler payla\u015fan Hacettepe \u00dcniversitesi \u00c7ocuk Enfeksiyon B\u00f6l\u00fcm\u00fc \u00d6\u011fretim G\u00f6revlisi Prof. Dr. Ate\u015f Kara ile birlikte t\u00fcm bebekleri kapsayan korunma stratejilerinin gereklili\u011fine dikkat \u00e7eken Malhan, \u201cRSV\u2019ye kar\u015f\u0131 geli\u015ftirilecek b\u00fct\u00fcnc\u00fcl ve yenilik\u00e7i \u00e7\u00f6z\u00fcmlerle sa\u011fl\u0131k sistemindeki y\u00fck ve ailelerin ya\u015fad\u0131\u011f\u0131 zorluklar \u00f6nemli \u00f6l\u00e7\u00fcde azaltabilir. Sa\u011fl\u0131\u011fa ayr\u0131lm\u0131\u015f \u00e7ok daha k\u0131t kaynaklar, korunma ve \u00f6nleme stratejileriyle \u00e7ok daha etkili \u015fekilde kullan\u0131labilir\u201d dedi.<\/p>\n\n\n\n

\u201cRSV\u2019ye kar\u015f\u0131 fark\u0131ndal\u0131k ve korunma kritik \u00f6nem ta\u015f\u0131yor\u201d<\/strong><\/p>\n\n\n\n

Hacettepe \u00dcniversitesi \u00c7ocuk Enfeksiyon B\u00f6l\u00fcm\u00fc \u00d6\u011fretim G\u00f6revlisi<\/strong> Prof. Dr. Ate\u015f Kara<\/strong> RSV hakk\u0131nda \u00f6nemli bilgiler payla\u015ft\u0131: \u201cRSV, 2 ya\u015f\u0131na kadar bebeklerin neredeyse tamam\u0131n\u0131 enfekte eden yayg\u0131n ve bula\u015f\u0131c\u0131 bir vir\u00fcs. En \u00f6nemli nokta \u015fu ki, sa\u011fl\u0131kl\u0131 do\u011fan veya risk fakt\u00f6rleri ile do\u011fan, miad\u0131nda do\u011fan veya premat\u00fcre do\u011fan, sezonda veya \u00f6ncesinde do\u011fan t\u00fcm bebekler RSV riski ile kar\u015f\u0131 kar\u015f\u0131ya. Hangi bebe\u011fin a\u011f\u0131r etkilenece\u011fini \u00f6ng\u00f6remedi\u011fimiz i\u00e7in ve RSV hastal\u0131\u011f\u0131na kar\u015f\u0131 spesifik bir tedavi bulunmad\u0131\u011f\u0131 i\u00e7in, RSV\u2019ye kar\u015f\u0131 \u00f6nleyici tedbirler ve hijyen uygulamalar\u0131 kritik \u00f6nem ta\u015f\u0131yor.\u201d<\/p>\n\n\n\n

\u00c7al\u0131\u015fman\u0131n tamam\u0131na a\u015fa\u011f\u0131daki linkten ula\u015f\u0131labiliyor:<\/p>\n\n\n\n

\nhttps:\/\/bikumm.baskent.edu.tr\/kw\/upload\/1033\/dosyalar\/rsv-hastalik-raporu-yuksek.pdf?did=206863\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"

\u2018T\u00fcrkiye\u2019de Respiratuar Sinsityal Vir\u00fcs (RSV) Enfeksiyonu Ekonomik Y\u00fck \u00c7al\u0131\u015fmas\u0131\u2019 sonu\u00e7lar\u0131 a\u00e7\u0131kland\u0131. \u00dclkemizde bir ilk olma \u00f6zelli\u011fine sahip olan \u00e7al\u0131\u015fmaya g\u00f6re RSV\u2019nin \u00fclkemizdeki maliyeti 24 milyar TL\u2019yi a\u015f\u0131yor.<\/p>\n

Bebeklerde ya\u015fam\u0131 tehdit eden \u015fiddetli solunum yolu enfeksiyonlar\u0131na yol a\u00e7an RSV\u2019yi konu alan bu ilk raporun sonu\u00e7lar\u0131n\u0131 Ba\u015fkent \u00dcniversitesi Sa\u011fl\u0131k Y\u00f6netimi B\u00f6l\u00fcm\u00fc \u00d6\u011fretim \u00dcyesi Prof. Dr. Simten Malhan bug\u00fcn bir bas\u0131n toplant\u0131s\u0131nda a\u00e7\u0131klad\u0131. Bas\u0131n toplant\u0131s\u0131na kat\u0131lan Hacettepe \u00dcniversitesi \u00c7ocuk Enfeksiyon B\u00f6l\u00fcm\u00fc \u00d6\u011fretim G\u00f6revlisi Prof Dr. Ate\u015f Kara da RSV hakk\u0131nda \u00f6nemli bilgiler payla\u015ft\u0131.<\/p>\n","protected":false},"author":1,"featured_media":4161,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4160"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4160"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4160\/revisions"}],"predecessor-version":[{"id":4162,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4160\/revisions\/4162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4161"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}